Skip to main content
Erschienen in: Gut Pathogens 1/2012

Open Access 01.12.2012 | Letter to the Editor

Intestinal dysbacteriosis induces changes of T lymphocyte subpopulations in Peyer’s patches of mice and orients the immune response towards humoral immunity

verfasst von: Fei Gao, Ming Li, Yinhui Liu, Chuanzhou Gao, Shu Wen, Li Tang

Erschienen in: Gut Pathogens | Ausgabe 1/2012

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

The large numbers of human intestinal microorganisms have a highly co-evolved relationship with the immune system. Dysbacteriosis of intestinal microbiota induces alterations of immune responses, and is closely related to disease development. Peyer’s patches are immune sensors in intestine which exert essential functions during development of inflammatory disease. However, interactions between commensal bacteria and PPs have been poorly characterized. In this study, changes of lymphocyte subpopulations and production of cytokines in PPs of mice with intestinal dysbacteriosis were investigated. The ceftriaxone-induced dysbacteriosis caused a notable change in populations of T lymphocytes, their subpopulations in PPs and expressions of various cytokines. Our results suggest intestinal dysbacteriosis in mice reduces immune tolerance in PPs and orients immune response towards humoral immunity.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1757-4749-4-19) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LT and SW designed the research; FG and ML performed the experiments; ML and YL analyzed the data; ML, CG, SW and LT wrote this paper. FG and ML contributed equally to this work. All authors read and approved the final manuscript.

Background

Intestinal microorganisms are required for proper development of the immune system, as indicated by the fact that germ-free (GF) mice have poorly developed lymphoid tissues [1]. Under normal conditions, gut microflora exists in a state of equilibrium with host that is mutually beneficial to the degree that it has been described as a separate ‘organ’ adapted to human physiology [2]. However, factors such as antibiotics abuse, stress, or nutritional deficiencies can seriously disrupt this delicate balance, resulting in altered immune responses and disease. In IBD patients, the quantity of commensal bacteria in the intestine is reduced, diversity of microbiota is also altered [3, 4]. Patients with IBD exhibit disruption in mucosal integrity, dysfunction of gut-associated lymphoid tissue (GALT), and deregulated immune tolerance [5, 6]. Nevertheless, whether microbial dysbiosis in the gut is the cause of dysfunction in GALT, and of reduced immune tolerance, are as yet poorly documented. Peyer’s patches (PPs) are major component of GALT. Lacking of PPs and lymph nodes would develop more severe colitis in mice [7], suggesting PPs’ importance in exerting immune functions during the development of IBD. The participation of PPs in inflammatory disorders and their interplay with gut microbiota is thus becoming an interesting field of research.

Study design and results

We hypothesized that alterations in gut microflora may induce changes of cellular composition and cytokine productions in PPs, and lead to a shift in immune response/tolerance. To test this, we established mouse models with dysbacteriosis through intragastric administration of ceftriaxone sodium. Alterations of lymphocytes in PPs (particularly the T lymphocyte subpopulations) were examined, as was cytokine mRNA expression (Additional file 1: Supplementary material). The population of commensal bacteria was found reduced in mice treated with ceftriaxone sodium and some are even eradicated (Additional file 2: Table S1). The structure of intestinal microflora was seriously disrupted. The population of CD3+ T cells, which represents the level of cell-mediated immune response, was detected by flow cytometry. Compared with control mice, the total level of CD3+ T cells in PPs of mild dysbacteriosis mice increased to 22.2%, and to 26.9% in PPs of the severe group (Figure 1a). The T lymphocyte subpopulations were also examined. Results in Figure 1b show that CD4+ T cells in PPs of mild and severe dysbacteriosis mice increased by 7.37% and 5.15%, respectively. In contrast, the CD8+ T cells in PPs of mice with dysbacteriosis decreased from 5.85% to no more than 3.60%, resulting in a higher ratio of CD4+/CD8+ compared with healthy mice (Figure 1c). Changes in CD4+/CD8+ ratio are normally considered as an important reference to predict the shifting of immune responses. The increased proportion of CD4+/CD8+ indicates that intestinal dysbacteriosis has induced humoral immunity in mice. The populations of CD4+CD25+ T cells in PPs of healthy and dysbacteriosis mice were also detected. CD4+CD25+ are marker molecules on the surface of regulatory T cells (Treg cells), which are crucial for maintenance of immunological tolerance [8]. In PPs of dysbacteriosis mice groups, the regulatory CD4+CD25+ T cells were severely decreased (Figure 1c). These striking decreases indicate a significant reduction of immunological tolerance. The transforming growth factor-beta (TGF-β) is a critical regulator for the development of Treg cells, which are crucial for the maintenance of immunological tolerance [9]; we therefore detected the mRNA expression levels of TGF-β gene. As shown in Figure 2, a decreasing pattern was observed in dysbacteriosis mice groups, which suggested a delay of Treg cells development. This is basically correlated with the trends that have seen for the population of CD4+CD25+ T cells. Th cells represent a functionally heterogeneous population, comprising mainly two distinct subsets (termed Th1 and Th2 cells), defined by their cytokine secretion profiles [20]. Th1 cells produce IL-2, IFN-γ and tumour necrosis factor-beta (TNF-β), and promote both macrophage activation, and the production of complement fixing and opsonising antibodies. Th2 cells, which synthesize cytokines such as IL-4, IL-10 and etc., provide optimal help for antibody production, promote mast cell growth, eosinophil differentiation and activation, resulting in humoral or allergic responses [10]. In the present study, a slight decrease (by 10.7%) of Il2 gene expression was observed in PPs of mice with mild dysbacteriosis, while a dramatic decrease (by 60.9%) was observed in the severe group (Figure 2). The mRNA levels of the Ifng gene also decreased (by 20.4% and 37.4%, respectively). Expression of the Il4 gene in PPs of mice with mild dysbacteriosis increased by 23.6% compared with control, and it was 36.4% higher in the severe group. Expression of the Il10 gene increased dramatically in PPs of both mild (by 98.9%) and severe (by 200.4%) groups. The decrease in mRNA levels of Il2 and Ifng in PPs of dysbacteriosis mice suggest activation and proliferation of Th2 cells, while the elevation of Il4 and Il10 inhibit Th1 cells. Results in Figure 2 thus support the observation that dysbacteriosis in mice has induced a shifting of immune responses in PPs towards humoral immunity.

Conclusions

The present work describes the effects of intestinal dysbacteriosis on immune responses of PPs in mice. This disturbance in mice can be induced by ceftriaxone sodium, making it an ideal animal model to mimic gut dysbacteriosis in human. Also, this is the first study to document changes in T lymphocyte subpopulations and cytokine mRNA expression of PPs in response to intestinal dysbacteriosis. Dysbacteriosis induced a notable change in overall population of T lymphocytes, and in T lymphocyte subpopulations, in PPs, as well as altering the mRNA expression of various cytokines. These data suggest that immune tolerance in PPs is reduced after the administration of antibiotics, and the immune response has shifted to humoral immunity. However, relevance of these observations requires further study.

Acknowledgements

This work was supported by grants from National Program on Key Basic Research Project (973 Program, 2013CB531405), and the National Natural Science Foundation of China (NSFC, No.81150014).
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

LT and SW designed the research; FG and ML performed the experiments; ML and YL analyzed the data; ML, CG, SW and LT wrote this paper. FG and ML contributed equally to this work. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science. 2005, 308: 1635-1638. 10.1126/science.1110591.PubMedCentralCrossRefPubMed Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science. 2005, 308: 1635-1638. 10.1126/science.1110591.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. 2007, 104: 13780-13785. 10.1073/pnas.0706625104.PubMedCentralCrossRefPubMed Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. 2007, 104: 13780-13785. 10.1073/pnas.0706625104.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J: Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006, 55: 205-211. 10.1136/gut.2005.073817.PubMedCentralCrossRefPubMed Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J: Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006, 55: 205-211. 10.1136/gut.2005.073817.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, Timmis KN, Schreiber S: Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004, 53: 685-693. 10.1136/gut.2003.025403.PubMedCentralCrossRefPubMed Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, Timmis KN, Schreiber S: Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004, 53: 685-693. 10.1136/gut.2003.025403.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Chandran P, Satthaporn S, Robins A, Eremin O: Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon. 2003, 1: 63-75. 10.1016/S1479-666X(03)80118-X.CrossRefPubMed Chandran P, Satthaporn S, Robins A, Eremin O: Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon. 2003, 1: 63-75. 10.1016/S1479-666X(03)80118-X.CrossRefPubMed
6.
Zurück zum Zitat Chandran P, Satthaporn S, Robins A, Eremin O: Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon. 2003, 1: 125-136. 10.1016/S1479-666X(03)80091-4.CrossRefPubMed Chandran P, Satthaporn S, Robins A, Eremin O: Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon. 2003, 1: 125-136. 10.1016/S1479-666X(03)80091-4.CrossRefPubMed
7.
Zurück zum Zitat Spahn TW, Herbst H, Rennert PD, Lugering N, Maaser C, Kraft M, Fontana A, Weiner HL, Domschke W, Kucharzik T: Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am J Pathol. 2002, 161: 2273-2282. 10.1016/S0002-9440(10)64503-8.PubMedCentralCrossRefPubMed Spahn TW, Herbst H, Rennert PD, Lugering N, Maaser C, Kraft M, Fontana A, Weiner HL, Domschke W, Kucharzik T: Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am J Pathol. 2002, 161: 2273-2282. 10.1016/S0002-9440(10)64503-8.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Watanabe N, Wang YH, Lee HK, Ito T, Cao W, Liu YJ: Hassall's Corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005, 436: 1181-1185. 10.1038/nature03886.CrossRefPubMed Watanabe N, Wang YH, Lee HK, Ito T, Cao W, Liu YJ: Hassall's Corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005, 436: 1181-1185. 10.1038/nature03886.CrossRefPubMed
9.
Zurück zum Zitat Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K: Induction of colonic regulatory T cells by indigenous clostridium species. Science. 2011, 331 (6015): 337-341. 10.1126/science.1198469.PubMedCentralCrossRefPubMed Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K: Induction of colonic regulatory T cells by indigenous clostridium species. Science. 2011, 331 (6015): 337-341. 10.1126/science.1198469.PubMedCentralCrossRefPubMed
Metadaten
Titel
Intestinal dysbacteriosis induces changes of T lymphocyte subpopulations in Peyer’s patches of mice and orients the immune response towards humoral immunity
verfasst von
Fei Gao
Ming Li
Yinhui Liu
Chuanzhou Gao
Shu Wen
Li Tang
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
Gut Pathogens / Ausgabe 1/2012
Elektronische ISSN: 1757-4749
DOI
https://doi.org/10.1186/1757-4749-4-19

Weitere Artikel der Ausgabe 1/2012

Gut Pathogens 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.